Rixensart, Belgium

Marguerite Deschamps

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marguerite Deschamps. Retrieved from https://idiyas.com/inventor/marguerite-deschamps

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marguerite Deschamps: Innovator in Vaccine Development

Introduction

Marguerite Deschamps is a notable inventor based in Rixensart, Belgium. She has made significant contributions to the field of vaccine development, particularly in bacterial polysaccharide antigen vaccines. Her work has implications for public health and disease prevention.

Latest Patents

Marguerite Deschamps holds 1 patent related to her innovative work. The patent focuses on bacterial polysaccharides conjugated to protein D, which is crucial for the development of effective vaccines. This invention represents a significant advancement in vaccine technology.

Career Highlights

Deschamps has built a career at GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. Her expertise in vaccine research has positioned her as a key figure in the development of new immunization strategies.

Collaborations

Throughout her career, Marguerite has collaborated with esteemed colleagues, including Carine Capiau and Pierre Michel Desmons. These partnerships have fostered innovation and enhanced the impact of her research.

Conclusion

Marguerite Deschamps exemplifies the spirit of innovation in the field of vaccine development. Her contributions continue to influence the landscape of public health and immunization.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…